Norges Bank
TARS icon

Norges Bank’s Tarsus Pharmaceuticals TARS Stock Holding History

Norges Bank’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
+16,672
New +$1.07M ﹤0.01% 1577
2026
Q1 		– Sell
-117,592
Closed -$9.63M – 1245
2025
Q4 		$9.63M Buy
+117,592
New +$8.78M ﹤0.01% 1313
2025
Q3 		– Sell
-471,354
Closed -$19.1M – 1389
2025
Q2 		$19.1M Buy
471,354
+80,293
+21% +$3.61M ﹤0.01% 1194
2025
Q1 		$20.1M Buy
+391,061
New +$19.3M ﹤0.01% 1201
2024
Q2 		– Sell
-160,100
Closed -$5.82M – 1983
2024
Q1 		$5.82M Hold
160,100
– – ﹤0.01% 1589
2023
Q4 		$3.24M Buy
+160,100
New +$2.67M ﹤0.01% 1743

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Norges Bank's TARS Position: Q2 2026 in Review

Norges Bank opened a new position in Tarsus Pharmaceuticals (TARS) in Q2 2026: 16,672 shares worth $1.05M. The stake represents ﹤0.01% of the portfolio and ranks #1577 among its holdings. This is a return to the name: Norges Bank previously reported a position in TARS as recently as Q4 2025.

Norges Bank first reported a position in TARS in Q4 2023 and has held it in 6 quarters since. The position peaked at $20.1M in Q1 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Norges Bank held 16,672 shares of Tarsus Pharmaceuticals worth $1.05M as of Q2 2026.
  • Tarsus Pharmaceuticals was a new Norges Bank position in Q2 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1577 holding.
  • Norges Bank first reported a position in Tarsus Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
  • Norges Bank's Tarsus Pharmaceuticals position peaked at $20.1M in Q1 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.